Answers are grounded in this paper and cite their sources.
INTRODUCTION Molecular classification in gastric cancer has identified relevant disease heterogeneity with prognostic implications. However, limited comparative analysis of molecular classification systems has occurred. We assessed the effect of the Tumour Microenvironment Score (TME), the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) classification systems on disease-free interval (DFI) and disease-specific survival (DSS) in Stage I-III gastric cancer. METHODS Previously characterized machine learning models were used to assign TCGA, ACRG and TME molecular classes to stage I-III patients in the ACRG and TCGA datasets (n=523). DFI and DSS was assessed using univariable and multivariable Cox Proportional Hazards models. RESULTS A multivariable Cox model including TCGA, ACRG and TME subtypes showed that only a high TME score was associated with improved DFI (HR 0.22 [95% CI 0.10, 0.49]; p < 0.001) and DSS (HR 0.2 [95% CI 0.09-0.43]; p < 0.001). The significant effect of TME High score was maintained after sensitivity analysis that adjusted for stage, age, sex, chemotherapy, radiation, tumour location, and study (DFI: TME High HR 0.33 [95% CI 0.15, 0.73)]; p < 0.01 and DSS: TME High HR 0.21 [95% CI 0.08, 0.52)]; p < 0.001). CONCLUSIONS In an integrated analysis comparing TCGA, ACRG and TME scores, a high TME score is the only independent molecular prognostic factor for DFI and DSS in non-metastatic gastric cancer. Additional investigation into implications of the heterogeneity of the TME score relative to the TCGA and ACRG classifications may yield additional insight into gastric cancer biology and treatment. Synopsis We compared the prognostic relevance of multiple molecular classification methods in gastric cancer using a previously developed machine learning model. The Tumour Microenvironment Score, which indicates an active immune microenvironment, was the only significant independent prognostic factor for disease-free interval and disease-specific survival.
No takes yet. Share an insight, caveat, or question.
Skubleny et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: